The Pharmacy Times® Mental Health resource center provides a home where mental health experts and pharmacists can meet to learn about the latest clinical news from the field. With articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content, this is a one-stop shop for folks in both professions.
The Pacific Ketamine Institute is now offering esketamine nasal spray (Spravato, Johnson & Johnson) for the treatment of patients who don't respond well to traditional oral antidepressants. It is a prescription medication to be used alongside an oral antidepressant.1
NAMI Basics OnDemand is an adaptation of the in-person NAMI Basics, a free, 6-session education program for parents, caregivers, and other family who provide care for adolescents aged 22 years or younger who are experiencing mental health symptoms.
The National Institute on Aging (NIA) has launched 2 new research centers, the Alzheimer Centers for the Discovery of New Medicines, designed to diversify and strengthen the Alzheimer disease drug development pipeline.
Patients diagnosed with depression need a team of clinicians to provide support and encouragement. For pharmacists, this translates into a need to provide counseling that addresses a patient’s daily challenges, ability to seek and escalate treatment, and capacity to remain adherent.
Genomind is expanding its mental health genetic testing services with the addition of Genomind Professional PGx Express, which provides a more focused report and set of services to enhance the preexisting mental health genetic test.
Pharmacy and public health associations have released statements following the recent shootings in California, Texas, and Ohio, and some are discussing what actions they can take to prevent further gun-related injury and death.
The Pharmacy Times® Mental Health specialty page serves as a hub for all clinical news and articles related to mental health conditions, including: anxiety, eating disorders, and, depression. The coverage includes breaking news coverage of therapies recently approved by the US Food and Drug Administration, key takeaways from the latest clinical trials, and notifications of updates to clinical guidelines for countless conditions.